RecruitingNCT04199299

Sensors for Communication for Persons Who Cannot Communicate Unequivocally

The Use of Sensors to Improve Communication for Persons With Intellectual Disability Who Cannot Communicate Unequivocally


Sponsor

University of Oslo

Enrollment

100 participants

Start Date

Feb 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Some persons with intellectual disability or comprehensive cerebral palsy cannot communicate unequivocally how they are, how they react to situations and people, whether they are in pain or experience discomfort, anger or fear. Their modes of communication (sounds, grimacing etc) may be unintelligible or ambiguous to their caregivers. With the use of heart and/or respiration monitors the investigators aim to give these persons a means to communicate their immediate reactions or responses. The respiration monitor is meant to register sleep at night, so that the participants can communicate whether they have slept well or not the previous night.


Eligibility

Min Age: 5 YearsMax Age: 80 Years

Inclusion Criteria1

  • intellectual disability with or without autism and/or cerebral palsy that render the participant unable to communicate his/her needs and reactions unequivocally.

Exclusion Criteria1

  • allergic skin reaction to chest strap

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHeart rate and respiration rate sensors

The use of sensors to monitor physiological variables (e.g. heart rate, sleep). The design is a before-and-after comparison with respect to whether the use of sensors has changed the caregivers' practice and their (perceived) understanding of the participant. The frequency of participants' self harm or aggressive behavior after as compared to before the introduction of pulse- and respiration monitors will also be charted.


Locations(1)

University of Oslo

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04199299


Related Trials